Kirn David (CIK 0001834021)

Latest company ownership

Shares held
1,270
Last filed at
Jul 12, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jul 10, 2024 Jul 12, 2024 4D Molecular Therapeutics, Inc. CEO Sell 42.5 -12,923 -1.21% ✓ $290.6K
Jun 24, 2024 Jun 26, 2024 4D Molecular Therapeutics, Inc. CEO Sell 42.5 -12,930 -1.21% ✓ $298.7K
Feb 8, 2024 Feb 12, 2024 4D Molecular Therapeutics, Inc. CEO Sell 23.8 -92,001 -7.99% ✓ $2.5M
Jan 23, 2024 Jan 25, 2024 4D Molecular Therapeutics, Inc. CEO Sell 48.8 -5,696 -0.49% ✓ $104.9K
Dec 15, 2023 Jan 8, 2024 4D Molecular Therapeutics, Inc. CEO Sell 23.8 -102,303 -8.12% ✓ $2M
Feb 21, 2023 Feb 23, 2023 4D Molecular Therapeutics, Inc. CEO Sell 42.5 -34,446 -1.82% ✓ $709.9K
Jan 19, 2023 Jan 23, 2023 4D Molecular Therapeutics, Inc. CEO Sell 42.5 -19,524 -1.02% ✓ $392.5K
Dec 15, 2022 Dec 19, 2022 4D Molecular Therapeutics, Inc. CEO Sell 32.5 -86,877 -4.34% ✓ $2M